Detalhe da pesquisa
1.
The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception.
J Pharmacol Exp Ther
; 389(1): 5-14, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699710
2.
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans.
Molecules
; 28(12)2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37375350
3.
Altered sleep during spontaneous cannabinoid withdrawal in male mice.
Behav Pharmacol
; 33(2&3): 195-205, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288510
4.
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists.
Molecules
; 27(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36234992
5.
Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Int J Neuropsychopharmacol
; 24(8): 656-665, 2021 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909067
6.
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments.
Molecules
; 25(11)2020 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517185
7.
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.
J Pharmacol Exp Ther
; 371(2): 544-554, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413139
8.
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538.
J Pharmacol Exp Ther
; 364(3): 485-493, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311110
9.
Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.
J Pharmacol Exp Ther
; 358(2): 334-41, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27231154
10.
Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent mice.
Drug Alcohol Depend
; 255: 110967, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150894
11.
Diuretic effects of cannabinoids.
J Pharmacol Exp Ther
; 344(1): 8-14, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23019138
12.
Ethanol self-administration in rats responding under concurrent schedules for milk or ethanol plus milk.
Behav Pharmacol
; 24(5-6): 486-95, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903243
13.
Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice.
Behav Pharmacol
; 23(8): 802-5, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075707
14.
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.
Eur J Med Chem
; 230: 114027, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051750
15.
Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.
J Pharmacol Exp Ther
; 336(2): 488-95, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21051498
16.
Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.
Pharmacol Biochem Behav
; 202: 173112, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33444603
17.
Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux.
J Pharmacol Exp Ther
; 333(3): 834-43, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20190012
18.
Cannabinoid-induced lower lip retraction in rats.
Psychopharmacology (Berl)
; 236(4): 1199-1206, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30460515
19.
Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys.
Psychopharmacology (Berl)
; 198(4): 521-8, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17882403
20.
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.
Physiol Behav
; 93(4-5): 666-70, 2008 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18076956